Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized control trial comparing efficacy of brand versus generic diacerein (DIACERIC) for osteoarthritis knee treatment
TCTR20240514004Phase 3Unknown
- Sponsor
- Millimed
- Start
- Feb 2023
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diacerein in osteoarthritis (OA), sponsored by Millimed. Status: unknown.
02
Drugs
diacerein
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on TCTR20240514004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240514004.